Molina Healthcare (MOH) Financials

$326.38 +1.03 (+0.32%)

As of 05/20/2025 03:59 PM Eastern

Annual Income Statements for Molina Healthcare

This table shows Molina Healthcare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Income / (Loss) Attributable to Common Shareholders	1,179	1,091	792	659	673	737	707	-512	52	143
Consolidated Net Income / (Loss)	1,179	1,091	792	659	673	737	707	-512	52	143
Net Income / (Loss) Continuing Operations	1,179	1,091	792	659	673	737	707	-512	52	143
Total Pre-Tax Income	1,589	1,464	1,063	875	961	972	999	-612	205	322
Total Operating Income	1,707	1,573	1,173	1,020	1,078	1,044	1,131	-555	306	387
Total Gross Profit	6,222	5,403	4,799	4,067	3,603	2,924	3,389	2,318	17,297	13,985
Total Revenue	40,650	34,072	31,974	27,771	19,423	16,829	18,890	19,883	17,782	14,178
Operating Revenue	40,650	34,072	31,974	27,771	19,423	16,829	18,890	19,883	17,782	14,178
Total Cost of Revenue	34,428	28,669	27,175	23,704	15,820	13,905	15,501	17,565	485	193
Operating Cost of Revenue	34,428	28,669	27,175	23,704	15,820	13,905	15,501	17,565	485	193
Total Operating Expenses	4,515	3,830	3,626	3,047	2,525	1,880	2,258	2,873	16,991	13,598
Selling, General & Admin Expense	2,843	2,590	2,369	2,129	1,511	1,302	1,394	1,594	1,393	1,146
Depreciation Expense	186	171	176	131	88	89	99	137	139	104
Other Operating Expenses / (Income)	1,486	1,069	873	787	926	489	765	438	15,459	12,348
Impairment Charge	0.00	0.00	208	0.00	0.00	-	-	470	0.00	0.00
Total Other Income / (Expense), net	-118	-109	-110	-145	-117	-72	-132	-57	-101	-65
Interest Expense	118	109	110	120	102	87	115	118	101	66
Income Tax Expense	410	373	271	216	288	235	292	-100	153	179
Basic Earnings per Share	$20.52	$18.91	$13.72	$11.40	$11.40	$11.85	$11.57	($9.07)	$0.93	$2.75
Weighted Average Basic Shares Outstanding	57.40M	57.70M	57.80M	57.80M	59M	62.20M	61.10M	56.40M	55M	52M
Diluted Earnings per Share	$20.42	$18.77	$13.55	$11.25	$11.23	$11.47	$10.61	($9.07)	$0.92	$2.58
Weighted Average Diluted Shares Outstanding	57.70M	58.10M	58.50M	58.60M	59.90M	64.20M	66.60M	56.40M	56.20M	56M
Weighted Average Basic & Diluted Shares Outstanding	55.50M	58.40M	57.90M	58.40M	58M	60.80M	61.10M	56.40M	55.90M	52M

This table shows Molina Healthcare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Income / (Loss) Attributable to Common Shareholders	298	251	326	301	301	216	245	309	321	56	230
Consolidated Net Income / (Loss)	298	251	326	301	301	216	245	309	321	56	230
Net Income / (Loss) Continuing Operations	298	251	326	301	301	216	245	309	321	56	230
Total Pre-Tax Income	390	346	438	406	399	289	332	416	427	78	307
Total Operating Income	433	380	467	434	426	316	359	443	455	105	335
Total Gross Profit	1,668	1,496	1,697	1,512	1,517	1,594	1,242	1,289	1,278	1,231	1,179
Total Revenue	11,147	10,499	10,340	9,880	9,931	9,048	8,548	8,327	8,149	8,223	7,927
Operating Revenue	11,147	10,499	10,340	9,880	9,931	9,048	8,548	8,327	8,149	8,223	7,927
Total Cost of Revenue	9,479	9,003	8,643	8,368	8,414	7,454	7,306	7,038	6,871	6,992	6,748
Operating Cost of Revenue	9,479	9,003	8,643	8,368	8,414	7,454	7,306	7,038	6,871	6,992	6,748
Total Operating Expenses	1,235	1,115	1,231	1,078	1,091	1,278	883	846	823	1,126	844
Selling, General & Admin Expense	799	684	676	734	749	740	608	635	607	644	576
Depreciation Expense	48	48	47	46	45	43	42	42	44	47	45
Other Operating Expenses / (Income)	388	383	508	298	297	495	233	169	172	227	223
Total Other Income / (Expense), net	-43	-34	-29	-28	-27	-27	-27	-27	-28	-27	-28
Interest Expense	43	34	29	28	27	27	27	27	28	27	28
Income Tax Expense	92	95	112	105	98	73	87	107	106	22	77
Basic Earnings per Share	$5.47	$4.46	$5.67	$5.18	$5.21	$3.72	$4.24	$5.37	$5.58	$0.98	$4.00
Weighted Average Basic Shares Outstanding	54.20M	57.40M	57.20M	58.60M	58.60M	57.70M	58.30M	58.30M	58.30M	57.80M	58.40M
Diluted Earnings per Share	$5.45	$4.43	$5.65	$5.17	$5.17	$3.69	$4.21	$5.35	$5.52	$0.96	$3.95
Weighted Average Diluted Shares Outstanding	54.20M	57.70M	57.20M	58.60M	58.60M	58.10M	58.30M	58.30M	58.30M	58.50M	58.40M
Weighted Average Basic & Diluted Shares Outstanding	54.20M	55.50M	57.20M	58.60M	58.60M	58.40M	58.30M	58.30M	58.30M	57.90M	58.40M

This table details how cash moves in and out of Molina Healthcare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Net Change in Cash & Equivalents	-167	860	-458	283	1,715	-418	-364	378	486	790
Net Cash From Operating Activities	644	1,662	773	2,119	1,898	434	-314	804	673	1,125
Net Cash From Continuing Operating Activities	644	1,662	773	2,119	1,898	434	-314	804	673	1,125
Net Income / (Loss) Continuing Operations	1,179	1,091	792	659	673	737	707	-512	52	143
Consolidated Net Income / (Loss)	1,179	1,091	792	659	673	737	707	-512	52	143
Depreciation Expense	186	171	176	131	88	89	127	178	182	126
Non-Cash Adjustments To Reconcile Net Income	-337	115	311	1,143	72	24	81	931	26	23
Changes in Operating Assets and Liabilities, net	-384	285	-506	186	1,065	-416	-1,229	175	382	803
Net Cash From Investing Activities	-464	-744	-790	-1,653	-400	-293	1,143	-1,062	-206	-1,420
Net Cash From Continuing Investing Activities	-464	-744	-790	-1,653	-400	-293	1,143	-1,062	-206	-1,420
Purchase of Property, Plant & Equipment	-100	-84	-91	-77	-74	-57	-30	-86	-176	-132
Acquisitions	-344	-3.00	-134	-129	-755	0.00	0.00	-	-48	-450
Purchase of Investments	-1,132	-1,433	-1,913	-2,713	-670	-2,536	-1,444	-2,697	-1,929	-1,929
Sale and/or Maturity of Investments	1,111	772	1,398	1,329	1,097	2,302	2,445	1,759	1,966	1,126
Other Investing Activities, net	1.00	4.00	-50	-63	2.00	-2.00	-18	-38	-19	-35
Net Cash From Financing Activities	-347	-58	-441	-183	217	-559	-1,193	636	19	1,085
Net Cash From Continuing Financing Activities	-347	-58	-441	-183	217	-559	-1,193	636	19	1,085
Repayment of Debt	-330	2.00	33	-722	-948	-211	-662	11	0.00	0.00
Repurchase of Common Equity	-1,000	0.00	-400	-128	-636	-561	-549	0.00	0.00	-
Issuance of Debt	1,040	0.00	0.00	740	1,809	220	18	625	19	694
Other Financing Activities, net	-57	-60	-74	-73	-8.00	-7.00	0.00	0.00	0.00	-
Cash Interest Paid	121	108	108	127	112	78	93	78	66	38
Cash Income Taxes Paid	379	405	340	235	321	239	240	7.00	153	197

This table details how cash moves in and out of Molina Healthcare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Net Change in Cash & Equivalents	214	-138	461	-154	-336	-712	663	360	549	-247	-83
Net Cash From Operating Activities	190	-224	873	-219	214	-690	949	487	916	-212	254
Net Cash From Continuing Operating Activities	190	-224	873	-219	214	-690	949	487	916	-212	254
Net Income / (Loss) Continuing Operations	298	251	326	301	301	216	245	309	321	56	230
Consolidated Net Income / (Loss)	298	251	326	301	301	216	245	309	321	56	230
Depreciation Expense	48	48	47	46	45	43	42	42	44	47	45
Non-Cash Adjustments To Reconcile Net Income	27	-435	73	-194	219	27	-477	270	295	231	-224
Changes in Operating Assets and Liabilities, net	-183	-88	427	-372	-351	-976	1,139	-134	256	-546	203
Net Cash From Investing Activities	-123	19	-48	53	-488	-25	-280	-137	-302	148	-347
Net Cash From Continuing Investing Activities	-123	19	-48	53	-488	-25	-280	-137	-302	148	-347
Purchase of Property, Plant & Equipment	-22	-11	-35	-27	-27	5.00	-26	-31	-32	-10	-31
Acquisitions	-245	-	-49	-	-295	-	-3.00	-	0.00	-	-
Purchase of Investments	-189	-143	-395	-214	-380	-138	-371	-278	-646	-149	-351
Sale and/or Maturity of Investments	331	240	365	295	211	102	124	175	371	316	203
Other Investing Activities, net	2.00	-67	66	-1.00	3.00	6.00	-4.00	-3.00	5.00	-9.00	-34
Net Cash From Financing Activities	147	67	-364	12	-62	3.00	-6.00	10	-65	-183	10
Net Cash From Continuing Financing Activities	147	67	-364	12	-62	3.00	-6.00	10	-65	-183	10
Repayment of Debt	33	-173	-163	12	-6.00	3.00	-5.00	11	-7.00	18	10
Repurchase of Common Equity	-500	-500	-	-	-	-	-	-	-	-200	-
Issuance of Debt	650	740	-	-	-	-	-	-	-	-	-
Other Financing Activities, net	-36	-	-1.00	-	-56	-	-1.00	-1.00	-58	-1.00	-

This table presents Molina Healthcare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Total Assets	15,630	14,892	12,314	12,209	9,532	6,787	7,154	8,471	7,449	6,576
Total Current Assets	12,773	12,542	10,084	10,064	7,876	5,967	6,462	7,511	5,988	5,306
Cash & Equivalents	4,662	4,848	4,006	4,438	4,154	2,452	2,826	3,186	2,819	2,329
Short-Term Investments	4,325	4,259	3,499	3,202	1,875	1,946	1,681	2,524	1,758	1,801
Accounts Receivable	3,299	3,104	2,302	2,177	1,672	1,406	1,330	871	974	597
Prepaid Expenses	487	331	277	247	175	163	149	239	131	192
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	241	342	454	393
Total Noncurrent Assets	2,857	2,350	2,230	2,145	1,656	820	451	618	1,007	877
Long-Term Investments	286	261	238	212	136	79	120	119	110	109
Goodwill	1,938	1,449	1,390	1,252	941	172	190	255	620	519
Noncurrent Deferred & Refundable Income Taxes	207	227	220	106	69	79	117	103	10	18
Other Noncurrent Operating Assets	426	413	382	575	510	490	24	141	127	109
Total Liabilities & Shareholders' Equity	15,630	14,892	12,314	12,209	9,532	6,787	7,154	8,471	7,449	6,576
Total Liabilities	11,134	10,677	9,350	9,579	7,436	4,827	5,507	7,134	5,800	5,019
Total Current Liabilities	7,896	8,168	6,855	7,047	4,965	3,269	4,246	5,557	4,570	3,822
Accounts Payable	1,331	1,252	889	842	641	502	390	366	385	362
Current Deferred Revenue	51	418	359	370	375	249	211	282	315	223
Other Current Liabilities	6,514	6,498	5,607	5,835	3,949	2,518	3,404	4,256	3,398	2,788
Total Noncurrent Liabilities	3,238	2,509	2,495	2,532	2,471	1,558	1,261	1,577	1,230	1,197
Long-Term Debt	2,923	2,180	2,176	2,173	2,127	1,237	1,020	1,318	975	962
Other Noncurrent Operating Liabilities	315	329	319	359	344	321	44	61	42	37
Total Equity & Noncontrolling Interests	4,496	4,215	2,964	2,630	2,096	1,960	1,647	1,337	1,649	1,557
Total Preferred & Common Equity	4,496	4,215	2,964	2,630	2,096	1,960	1,647	1,337	1,649	1,557
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,496	4,215	2,964	2,630	2,096	1,960	1,647	1,337	1,649	1,557
Common Stock	462	410	328	236	199	175	643	1,044	841	803
Retained Earnings	4,091	3,887	2,796	2,399	1,860	1,781	1,012	298	810	758
Accumulated Other Comprehensive Income / (Loss)	-57	-82	-160	-5.00	37	4.00	-8.00	-5.00	-2.00	-4.00

This table presents Molina Healthcare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Total Assets	16,386	15,630	15,758	15,185	15,513	14,892	14,870	13,661	13,371	12,314	12,793
Total Current Assets	13,257	12,773	12,881	12,331	12,668	12,542	12,468	11,441	11,159	10,084	10,492
Cash & Equivalents	4,856	4,662	4,732	4,354	4,513	4,848	5,565	4,910	4,554	4,006	4,242
Short-Term Investments	4,438	4,325	4,482	4,347	4,424	4,259	4,111	3,886	3,810	3,499	3,639
Accounts Receivable	3,491	3,299	3,259	3,231	3,350	3,104	2,460	2,385	2,536	2,302	2,220
Prepaid Expenses	472	487	408	399	381	331	332	260	259	277	391
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	3,129	2,857	2,877	2,854	2,845	2,350	2,402	2,220	2,212	2,230	2,301
Long-Term Investments	311	286	289	268	261	261	261	249	242	238	242
Goodwill	2,175	1,938	1,923	1,913	1,927	1,449	1,471	1,348	1,369	1,390	1,263
Noncurrent Deferred & Refundable Income Taxes	193	207	227	232	228	227	255	220	208	220	198
Other Noncurrent Operating Assets	450	426	438	441	429	413	415	403	393	382	598
Total Liabilities & Shareholders' Equity	16,386	15,630	15,758	15,185	15,513	14,892	14,870	13,661	13,371	12,314	12,793
Total Liabilities	12,076	11,134	10,988	10,342	11,020	10,677	10,991	10,040	10,083	9,350	9,752
Total Current Liabilities	8,155	7,896	8,337	7,836	8,514	8,168	8,492	7,537	7,614	6,855	7,242
Accounts Payable	1,119	1,331	1,215	973	1,114	1,252	1,090	857	787	889	818
Current Deferred Revenue	369	51	364	13	328	418	691	414	654	359	663
Other Current Liabilities	6,667	6,514	6,758	6,850	7,072	6,498	6,711	6,266	6,173	5,607	5,761
Total Noncurrent Liabilities	3,921	3,238	2,651	2,506	2,506	2,509	2,499	2,503	2,469	2,495	2,510
Long-Term Debt	3,574	2,923	2,332	2,181	2,180	2,180	2,179	2,178	2,177	2,176	2,175
Other Noncurrent Operating Liabilities	347	315	319	325	326	329	320	325	292	319	335
Total Equity & Noncontrolling Interests	4,310	4,496	4,770	4,843	4,493	4,215	3,879	3,621	3,288	2,964	3,041
Total Preferred & Common Equity	4,310	4,496	4,770	4,843	4,493	4,215	3,879	3,621	3,288	2,964	3,041
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	4,310	4,496	4,770	4,843	4,493	4,215	3,879	3,621	3,288	2,964	3,041
Common Stock	434	462	453	439	390	410	373	341	296	328	289
Retained Earnings	3,904	4,091	4,326	4,489	4,188	3,887	3,671	3,426	3,117	2,796	2,937
Accumulated Other Comprehensive Income / (Loss)	-28	-57	-9.00	-85	-85	-82	-165	-146	-125	-160	-185

This table displays calculated financial ratios and metrics derived from Molina Healthcare's official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020	12/31/2019	12/31/2018	12/31/2017	12/31/2016	12/31/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	19.31%	6.56%	15.13%	42.98%	15.41%	-10.91%	-4.99%	11.82%	25.42%	46.66%
EBITDA Growth	8.54%	29.28%	19.80%	-2.17%	0.26%	-7.49%	536.97%	-154.72%	-4.60%	54.11%
EBIT Growth	8.52%	34.10%	17.89%	-6.40%	0.38%	-4.94%	325.51%	-261.44%	-21.13%	102.08%
NOPAT Growth	8.05%	34.13%	13.77%	1.76%	-4.63%	-1.10%	306.03%	-600.52%	-54.84%	93.90%
Net Income Growth	8.07%	37.75%	20.18%	-2.08%	-8.68%	4.24%	238.09%	-1,084.62%	-63.64%	130.65%
EPS Growth	8.79%	38.52%	20.44%	0.18%	-2.09%	8.11%	216.98%	-1,085.87%	-64.34%	100.00%
Operating Cash Flow Growth	-61.25%	115.01%	-63.52%	11.64%	337.33%	238.22%	-139.05%	19.47%	-40.18%	6.13%
Free Cash Flow Firm Growth	-90.43%	260.37%	-77.18%	32.34%	157.82%	424.09%	-123.87%	78.69%	-17.48%	-41.76%
Invested Capital Growth	37.64%	-14.21%	14.63%	-57.00%	-51.72%	15.90%	38.92%	-78.89%	-29.82%	-40.63%
Revenue Q/Q Growth	3.70%	2.48%	2.61%	8.49%	5.21%	-2.26%	-1.49%	2.13%	3.87%	8.16%
EBITDA Q/Q Growth	3.78%	13.47%	-5.20%	8.27%	-10.64%	-3.37%	72.36%	-28,500.00%	-11.58%	-3.52%
EBIT Q/Q Growth	3.90%	15.49%	-6.83%	8.15%	-11.64%	-3.46%	102.18%	-127.65%	-21.13%	-4.79%
NOPAT Q/Q Growth	3.23%	15.83%	-7.25%	11.81%	-13.83%	-3.70%	137.41%	-90.07%	-54.72%	0.15%
Net Income Q/Q Growth	3.06%	17.19%	-5.60%	11.69%	-16.60%	-4.29%	189.75%	-72.39%	-59.69%	-2.44%
EPS Q/Q Growth	3.76%	17.02%	-5.44%	11.72%	-15.82%	-3.21%	263.36%	-71.78%	-60.00%	-6.52%
Operating Cash Flow Q/Q Growth	261.80%	-22.34%	-51.14%	-24.88%	198.90%	57.82%	8.72%	-19.36%	-21.01%	0.02%
Free Cash Flow Firm Q/Q Growth	158.76%	-22.27%	-60.53%	-22.13%	189.08%	-5.58%	60.64%	-18.01%	55.31%	-39.21%
Invested Capital Q/Q Growth	22.78%	23.36%	10.46%	-10.27%	-86.02%	10.49%	8.86%	-2.21%	-1.90%	16.33%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	15.31%	15.86%	15.01%	14.64%	18.55%	17.37%	17.94%	11.66%	97.27%	98.64%
EBITDA Margin	4.66%	5.12%	4.22%	4.05%	5.93%	6.82%	6.57%	-1.43%	2.92%	3.84%
Operating Margin	4.20%	4.62%	3.67%	3.67%	5.55%	6.20%	5.99%	-2.79%	1.72%	2.73%
EBIT Margin	4.20%	4.62%	3.67%	3.58%	5.47%	6.29%	5.90%	-2.48%	1.72%	2.74%
Profit (Net Income) Margin	2.90%	3.20%	2.48%	2.37%	3.47%	4.38%	3.74%	-2.58%	0.29%	1.01%
Tax Burden Percent	74.20%	74.52%	74.51%	75.31%	70.03%	75.82%	70.77%	83.66%	25.37%	44.41%
Interest Burden Percent	93.09%	93.07%	90.62%	87.94%	90.40%	91.78%	89.68%	123.89%	66.99%	82.99%
Effective Tax Rate	25.80%	25.48%	25.49%	24.69%	29.97%	24.18%	29.23%	0.00%	74.63%	55.59%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	27.07%	30.39%	28.32%	27.89%	33.19%	40.87%	47.39%	-34.29%	3.24%	11.14%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	11.19%	11.56%	9.57%	9.15%	13.03%	15.19%	14.26%	-6.21%	4.36%	7.05%
Return on Assets (ROA)	7.73%	8.02%	6.46%	6.06%	8.25%	10.57%	9.05%	-6.43%	0.74%	2.60%
Return on Common Equity (ROCE)	27.07%	30.39%	28.32%	27.89%	33.19%	40.87%	47.39%	-34.29%	3.24%	11.14%
Return on Equity Simple (ROE_SIMPLE)	26.22%	25.88%	26.72%	25.06%	32.11%	37.60%	42.93%	-38.29%	3.15%	9.18%
Net Operating Profit after Tax (NOPAT)	1,267	1,172	874	768	755	792	800	-389	78	172
NOPAT Margin	3.12%	3.44%	2.73%	2.77%	3.89%	4.70%	4.24%	-1.95%	0.44%	1.21%
Net Nonoperating Expense Percent (NNEP)	-1.29%	-1.27%	-1.46%	-2.25%	-2.25%	-1.70%	-2.67%	-3.59%	-0.90%	-1.31%
Return On Investment Capital (ROIC_SIMPLE)	17.07%	18.33%	17.00%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	84.69%	84.14%	84.99%	85.36%	81.45%	82.63%	82.06%	88.34%	2.73%	1.36%
SG&A Expenses to Revenue	6.99%	7.60%	7.41%	7.67%	7.78%	7.74%	7.38%	8.02%	7.83%	8.08%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.11%	11.24%	11.34%	10.97%	13.00%	11.17%	11.95%	14.45%	95.55%	95.91%
Earnings before Interest and Taxes (EBIT)	1,707	1,573	1,173	995	1,063	1,059	1,114	-494	306	388
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	1,893	1,744	1,349	1,126	1,151	1,148	1,241	-284	519	544
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.70	5.00	6.51	7.06	6.02	4.34	4.40	3.27	1.87	2.17
Price to Tangible Book Value (P/TBV)	6.51	7.62	12.25	13.48	10.92	4.76	4.98	4.05	3.47	3.68
Price to Revenue (P/Rev)	0.41	0.62	0.60	0.67	0.65	0.51	0.38	0.22	0.17	0.24
Price to Earnings (P/E)	14.12	19.31	24.35	28.19	18.74	11.54	10.26	0.00	59.29	23.58
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.08%	5.18%	4.11%	3.55%	5.34%	8.66%	9.75%	0.00%	1.69%	4.24%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.25	0.41	0.43	0.46	0.44	0.31	0.22	0.03	0.00	0.05
Enterprise Value to EBITDA (EV/EBITDA)	5.44	7.96	10.17	11.45	7.45	4.59	3.29	0.00	0.08	1.36
Enterprise Value to EBIT (EV/EBIT)	6.03	8.82	11.69	12.96	8.07	4.97	3.66	0.00	0.13	1.91
Enterprise Value to NOPAT (EV/NOPAT)	8.13	11.84	15.70	16.79	11.36	6.65	5.10	0.00	0.53	4.32
Enterprise Value to Operating Cash Flow (EV/OCF)	15.99	8.35	17.75	6.09	4.52	12.14	0.00	0.68	0.06	0.66
Enterprise Value to Free Cash Flow (EV/FCFF)	69.79	9.00	32.05	6.88	6.05	9.58	0.00	0.77	0.10	1.54
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.65	0.52	0.73	0.83	1.01	0.63	0.89	1.62	1.00	1.03
Long-Term Debt to Equity	0.65	0.52	0.73	0.83	1.01	0.63	0.74	1.13	0.71	0.75
Financial Leverage	-1.55	-1.78	-2.01	-2.06	-1.79	-1.78	-2.35	-2.30	-1.77	-1.72
Leverage Ratio	3.50	3.79	4.38	4.60	4.02	3.87	5.24	5.33	4.37	4.29
Compound Leverage Factor	3.26	3.53	3.97	4.05	3.64	3.55	4.70	6.61	2.93	3.56
Debt to Total Capital	39.40%	34.09%	42.33%	45.24%	50.37%	38.69%	46.96%	61.87%	49.94%	50.82%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.76%	18.63%	14.33%	14.18%
Long-Term Debt to Total Capital	39.40%	34.09%	42.33%	45.24%	50.37%	38.69%	39.19%	43.24%	35.61%	36.64%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	60.60%	65.91%	57.67%	54.76%	49.63%	61.31%	53.04%	38.13%	50.06%	49.18%
Debt to EBITDA	1.54	1.25	1.61	1.93	1.85	1.08	1.17	-7.64	3.17	2.96
Net Debt to EBITDA	-3.35	-4.12	-4.13	-5.04	-3.51	-2.82	-2.55	13.48	-5.86	-4.83
Long-Term Debt to EBITDA	1.54	1.25	1.61	1.93	1.85	1.08	0.98	-5.34	2.26	2.13
Debt to NOPAT	2.31	1.86	2.49	2.83	2.82	1.56	1.82	-5.58	21.19	9.36
Net Debt to NOPAT	-5.01	-6.13	-6.37	-7.39	-5.35	-4.09	-3.96	9.86	-39.19	-15.30
Long-Term Debt to NOPAT	2.31	1.86	2.49	2.83	2.82	1.56	1.52	-3.90	15.11	6.75
Altman Z-Score	4.60	4.54	4.78	4.28	4.06	4.90	4.51	2.85	3.22	3.19
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.62	1.54	1.47	1.43	1.59	1.83	1.52	1.35	1.31	1.39
Quick Ratio	1.56	1.50	1.43	1.39	1.55	1.78	1.37	1.18	1.21	1.24
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	148	1,542	428	1,875	1,417	550	-170	711	398	482
Operating Cash Flow to CapEx	644.00%	1,978.57%	849.45%	2,751.95%	2,564.86%	761.40%	-1,046.67%	934.88%	382.39%	852.27%
Free Cash Flow to Firm to Interest Expense	1.25	14.15	3.89	15.63	13.89	6.32	-1.47	6.02	3.94	7.30
Operating Cash Flow to Interest Expense	5.46	15.25	7.03	17.66	18.61	4.99	-2.73	6.81	6.66	17.05
Operating Cash Flow Less CapEx to Interest Expense	4.61	14.48	6.20	17.02	17.88	4.33	-2.99	6.08	4.92	15.05
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.66	2.50	2.61	2.55	2.38	2.41	2.42	2.50	2.54	2.58
Accounts Receivable Turnover	12.70	12.61	14.28	14.43	12.62	12.30	17.16	21.55	22.64	23.77
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	64.80	49.96	41.99	38.63
Accounts Payable Turnover	26.66	26.78	31.40	31.97	27.68	31.18	41.01	46.78	1.30	0.64
Days Sales Outstanding (DSO)	28.75	28.96	25.57	25.29	28.92	29.67	21.26	16.93	16.12	15.36
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	13.69	13.63	11.62	11.42	13.19	11.71	8.90	7.80	281.09	571.14
Cash Conversion Cycle (CCC)	15.05	15.33	13.94	13.88	15.74	17.96	12.36	9.13	-264.96	-555.78
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-1,854	-2,973	-2,603	-3,049	-1,942	-1,280	-1,522	-2,492	-1,393	-1,073
Invested Capital Turnover	-16.84	-12.22	-11.31	-11.13	-12.06	-12.01	-9.41	-10.24	-14.42	-15.44
Increase / (Decrease) in Invested Capital	1,119	-370	446	-1,107	-662	242	970	-1,099	-320	-310
Enterprise Value (EV)	10,298	13,876	13,718	12,897	8,574	5,268	4,082	549	41	742
Market Capitalization	16,648	21,064	19,285	18,576	12,612	8,508	7,251	4,378	3,083	3,372
Book Value per Share	$78.60	$72.30	$50.75	$45.03	$35.35	$31.26	$26.40	$23.42	$29.02	$27.76
Tangible Book Value per Share	$44.72	$47.44	$26.95	$23.60	$19.48	$28.52	$23.35	$18.95	$15.65	$16.33
Total Capital	7,419	6,395	5,140	4,803	4,223	3,197	3,105	3,506	3,294	3,166
Total Debt	2,923	2,180	2,176	2,173	2,127	1,237	1,458	2,169	1,645	1,609
Total Long-Term Debt	2,923	2,180	2,176	2,173	2,127	1,237	1,217	1,516	1,173	1,160
Net Debt	-6,350	-7,188	-5,567	-5,679	-4,038	-3,240	-3,169	-3,829	-3,042	-2,630
Capital Expenditures (CapEx)	100	84	91	77	74	57	30	86	176	132
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-4,110	-4,733	-4,276	-4,623	-3,118	-1,700	-2,050	-3,272	-2,687	-2,197
Debt-free Net Working Capital (DFNWC)	4,877	4,374	3,229	3,017	2,911	2,698	2,457	2,607	1,890	1,933
Net Working Capital (NWC)	4,877	4,374	3,229	3,017	2,911	2,698	2,216	1,954	1,418	1,484
Net Nonoperating Expense (NNE)	88	81	82	109	82	55	93	124	26	29
Net Nonoperating Obligations (NNO)	-6,350	-7,188	-5,567	-5,679	-4,038	-3,240	-3,169	-3,829	-3,042	-2,630
Total Depreciation and Amortization (D&A)	186	171	176	131	88	89	127	210	213	156
Debt-free, Cash-free Net Working Capital to Revenue	-10.11%	-13.89%	-13.37%	-16.65%	-16.05%	-10.10%	-10.85%	-16.46%	-15.11%	-15.50%
Debt-free Net Working Capital to Revenue	12.00%	12.84%	10.10%	10.86%	14.99%	16.03%	13.01%	13.11%	10.63%	13.63%
Net Working Capital to Revenue	12.00%	12.84%	10.10%	10.86%	14.99%	16.03%	11.73%	9.83%	7.97%	10.47%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$20.52	$18.91	$13.72	$11.40	$11.40	$11.85	$11.57	($9.07)	$0.93	$2.75
Adjusted Weighted Average Basic Shares Outstanding	57.40M	57.70M	57.80M	57.80M	59M	62.20M	61M	56M	55M	52M
Adjusted Diluted Earnings per Share	$20.42	$18.77	$13.55	$11.25	$11.23	$11.47	$10.61	($9.07)	$0.92	$2.58
Adjusted Weighted Average Diluted Shares Outstanding	57.70M	58.10M	58.50M	58.60M	59.90M	64.20M	67M	56M	56M	56M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	55.50M	58.40M	57.90M	58.40M	58M	60.80M	62.46M	59.73M	56.75M	56.20M
Normalized Net Operating Profit after Tax (NOPAT)	1,267	1,172	1,029	768	755	792	800	104	214	271
Normalized NOPAT Margin	3.12%	3.44%	3.22%	2.77%	3.89%	4.70%	4.24%	0.52%	1.20%	1.91%
Pre Tax Income Margin	3.91%	4.30%	3.32%	3.15%	4.95%	5.78%	5.29%	-3.08%	1.15%	2.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	14.47	14.43	10.66	8.29	10.42	12.17	9.69	-4.19	3.03	5.88
NOPAT to Interest Expense	10.73	10.75	7.95	6.40	7.40	9.10	6.96	-3.29	0.77	2.60
EBIT Less CapEx to Interest Expense	13.62	13.66	9.84	7.65	9.70	11.52	9.43	-4.92	1.29	3.88
NOPAT Less CapEx to Interest Expense	9.89	9.98	7.12	5.76	6.68	8.44	6.70	-4.02	-0.97	0.60
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	84.82%	0.00%	50.51%	19.42%	94.50%	76.12%	77.65%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Molina Healthcare's official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/30/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	12.24%	16.04%	20.96%	18.65%	21.87%	10.03%	7.83%	3.39%	4.88%	10.99%	12.60%
EBITDA Growth	2.12%	19.22%	28.18%	-1.03%	-5.61%	136.18%	5.53%	19.75%	21.12%	-32.74%	50.20%
EBIT Growth	1.64%	20.25%	30.08%	-2.03%	-6.37%	200.95%	7.16%	22.71%	22.31%	-45.03%	51.58%
NOPAT Growth	2.95%	16.72%	31.20%	-2.22%	-6.05%	213.30%	5.56%	22.76%	22.60%	-47.89%	51.68%
Net Income Growth	-1.00%	16.20%	33.06%	-2.59%	-6.23%	285.71%	6.52%	24.60%	24.42%	-45.63%	60.84%
EPS Growth	5.42%	20.05%	34.20%	-3.36%	-6.34%	284.38%	6.58%	25.88%	25.74%	-44.83%	60.57%
Operating Cash Flow Growth	-11.22%	67.54%	-8.01%	-144.97%	-76.64%	-225.47%	273.62%	32.34%	152.34%	-135.51%	-44.90%
Free Cash Flow Firm Growth	-60.59%	-239.12%	-191.39%	-303.14%	-167.26%	263.56%	214.76%	-44.34%	-60.50%	-129.61%	-79.17%
Invested Capital Growth	31.84%	37.64%	38.10%	40.08%	19.61%	-14.21%	-33.44%	-4.95%	-3.15%	14.63%	-5.14%
Revenue Q/Q Growth	6.17%	1.54%	4.66%	-0.51%	9.76%	5.85%	2.65%	2.18%	-0.90%	3.73%	-1.58%
EBITDA Q/Q Growth	12.38%	-16.73%	7.08%	1.91%	31.20%	-10.47%	-17.32%	-2.81%	228.29%	-60.00%	-6.17%
EBIT Q/Q Growth	13.95%	-18.63%	7.60%	1.88%	34.81%	-11.98%	-18.96%	-2.64%	333.33%	-68.66%	-7.20%
NOPAT Q/Q Growth	20.02%	-20.69%	8.03%	0.12%	36.07%	-10.85%	-19.49%	-3.80%	353.74%	-69.96%	-6.37%
Net Income Q/Q Growth	18.73%	-23.01%	8.31%	0.00%	39.35%	-11.84%	-20.71%	-3.74%	473.21%	-75.65%	-7.26%
EPS Q/Q Growth	23.02%	-21.59%	9.28%	0.00%	40.11%	-12.35%	-21.31%	-3.08%	475.00%	-75.70%	-7.06%
Operating Cash Flow Q/Q Growth	184.82%	-125.66%	498.63%	-202.34%	131.01%	-172.71%	94.87%	-46.83%	532.08%	-183.46%	-30.98%
Free Cash Flow Firm Q/Q Growth	43.90%	25.40%	-15.44%	-232.36%	-148.60%	-50.99%	156.59%	10.05%	218.20%	-194.31%	-54.62%
Invested Capital Q/Q Growth	7.17%	22.78%	-23.44%	22.97%	15.07%	23.36%	-19.50%	-3.34%	-20.67%	10.46%	6.01%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	14.96%	14.25%	16.41%	15.30%	15.28%	17.62%	14.53%	15.48%	15.68%	14.97%	14.87%
EBITDA Margin	4.32%	4.08%	4.97%	4.86%	4.74%	3.97%	4.69%	5.82%	6.12%	1.85%	4.79%
Operating Margin	3.88%	3.62%	4.52%	4.39%	4.29%	3.49%	4.20%	5.32%	5.58%	1.28%	4.23%
EBIT Margin	3.88%	3.62%	4.52%	4.39%	4.29%	3.49%	4.20%	5.32%	5.58%	1.28%	4.23%
Profit (Net Income) Margin	2.67%	2.39%	3.15%	3.05%	3.03%	2.39%	2.87%	3.71%	3.94%	0.68%	2.90%
Tax Burden Percent	76.41%	72.54%	74.43%	74.14%	75.44%	74.74%	73.80%	74.28%	75.18%	71.79%	74.92%
Interest Burden Percent	90.07%	91.05%	93.79%	93.55%	93.66%	91.46%	92.48%	93.91%	93.85%	74.29%	91.64%
Effective Tax Rate	23.59%	27.46%	25.57%	25.86%	24.56%	25.26%	26.20%	25.72%	24.82%	28.21%	25.08%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	26.72%	27.07%	26.45%	25.12%	27.53%	30.39%	26.91%	28.40%	28.12%	28.32%	30.19%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	10.20%	9.64%	11.56%	11.39%	10.65%	8.75%	10.10%	13.23%	14.04%	3.33%	11.05%
Return on Assets (ROA)	7.02%	6.37%	8.07%	7.90%	7.52%	5.98%	6.89%	9.23%	9.91%	1.78%	7.59%
Return on Common Equity (ROCE)	26.72%	27.07%	26.45%	25.12%	27.53%	30.39%	26.91%	28.40%	28.12%	28.32%	30.19%
Return on Equity Simple (ROE_SIMPLE)	27.29%	0.00%	23.98%	21.95%	23.84%	0.00%	24.00%	25.30%	26.00%	0.00%	27.59%
Net Operating Profit after Tax (NOPAT)	331	276	348	322	321	236	265	329	342	75	251
NOPAT Margin	2.97%	2.63%	3.36%	3.26%	3.24%	2.61%	3.10%	3.95%	4.20%	0.92%	3.17%
Net Nonoperating Expense Percent (NNEP)	-0.50%	-0.36%	-0.29%	-0.30%	-0.30%	-0.32%	-0.29%	-0.31%	-0.34%	-0.34%	-0.37%
Return On Investment Capital (ROIC_SIMPLE)	4.20%	3.72%	-	-	-	3.69%	-	-	-	1.47%	-
Cost of Revenue to Revenue	85.04%	85.75%	83.59%	84.70%	84.72%	82.38%	85.47%	84.52%	84.32%	85.03%	85.13%
SG&A Expenses to Revenue	7.17%	6.51%	6.54%	7.43%	7.54%	8.18%	7.11%	7.63%	7.45%	7.83%	7.27%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	11.08%	10.62%	11.91%	10.91%	10.99%	14.12%	10.33%	10.16%	10.10%	13.69%	10.65%
Earnings before Interest and Taxes (EBIT)	433	380	467	434	426	316	359	443	455	105	335
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	481	428	514	480	471	359	401	485	499	152	380
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.24	3.70	4.23	3.60	5.33	5.00	4.93	4.85	4.71	6.51	6.30
Price to Tangible Book Value (P/TBV)	8.56	6.51	7.09	5.95	9.33	7.62	7.94	7.73	8.07	12.25	10.78
Price to Revenue (P/Rev)	0.44	0.41	0.52	0.47	0.67	0.62	0.58	0.54	0.48	0.60	0.62
Price to Earnings (P/E)	15.55	14.12	17.65	16.39	22.36	19.31	20.53	19.17	18.11	24.35	22.84
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	6.43%	7.08%	5.67%	6.10%	4.47%	5.18%	4.87%	5.22%	5.52%	4.11%	4.38%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	0.29	0.25	0.33	0.28	0.47	0.41	0.34	0.33	0.28	0.43	0.42
Enterprise Value to EBITDA (EV/EBITDA)	6.44	5.44	7.14	6.22	9.87	7.96	7.39	7.05	6.31	10.17	9.29
Enterprise Value to EBIT (EV/EBIT)	7.15	6.03	7.92	6.93	10.97	8.82	8.34	7.99	7.21	11.69	10.50
Enterprise Value to NOPAT (EV/NOPAT)	9.60	8.13	10.61	9.29	14.70	11.84	11.22	10.72	9.67	15.70	14.03
Enterprise Value to Operating Cash Flow (EV/OCF)	19.76	15.99	73.15	41.87	17.64	8.35	5.31	7.40	6.83	17.75	8.35
Enterprise Value to Free Cash Flow (EV/FCFF)	25.97	69.79	0.00	0.00	31.62	9.00	5.72	9.29	8.77	32.05	12.19
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.83	0.65	0.49	0.45	0.49	0.52	0.56	0.60	0.66	0.73	0.72
Long-Term Debt to Equity	0.83	0.65	0.49	0.45	0.49	0.52	0.56	0.60	0.66	0.73	0.72
Financial Leverage	-1.48	-1.55	-1.73	-1.61	-1.73	-1.78	-1.98	-1.98	-2.02	-2.01	-2.02
Leverage Ratio	3.62	3.50	3.54	3.41	3.71	3.79	4.00	4.07	4.23	4.38	4.29
Compound Leverage Factor	3.26	3.19	3.32	3.19	3.48	3.47	3.70	3.82	3.97	3.26	3.93
Debt to Total Capital	45.33%	39.40%	32.84%	31.05%	32.67%	34.09%	35.97%	37.56%	39.84%	42.33%	41.70%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	45.33%	39.40%	32.84%	31.05%	32.67%	34.09%	35.97%	37.56%	39.84%	42.33%	41.70%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	54.67%	60.60%	67.16%	68.95%	67.33%	65.91%	64.03%	62.44%	60.16%	57.67%	58.30%
Debt to EBITDA	1.88	1.54	1.28	1.27	1.27	1.25	1.42	1.44	1.52	1.61	1.53
Net Debt to EBITDA	-3.17	-3.35	-3.93	-3.97	-4.09	-4.12	-5.05	-4.53	-4.48	-4.13	-4.18
Long-Term Debt to EBITDA	1.88	1.54	1.28	1.27	1.27	1.25	1.42	1.44	1.52	1.61	1.53
Debt to NOPAT	2.80	2.31	1.90	1.91	1.89	1.86	2.15	2.18	2.32	2.49	2.31
Net Debt to NOPAT	-4.73	-5.01	-5.84	-5.93	-6.09	-6.13	-7.67	-6.88	-6.86	-6.37	-6.31
Long-Term Debt to NOPAT	2.80	2.31	1.90	1.91	1.89	1.86	2.15	2.18	2.32	2.49	2.31
Altman Z-Score	4.26	4.32	4.42	4.34	4.41	4.26	4.03	4.24	4.10	4.49	4.33
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.63	1.62	1.55	1.57	1.49	1.54	1.47	1.52	1.47	1.47	1.45
Quick Ratio	1.57	1.56	1.50	1.52	1.44	1.50	1.43	1.48	1.43	1.43	1.39
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-473	-843	-1,130	-979	-295	606	1,237	482	438	-371	393
Operating Cash Flow to CapEx	863.64%	-2,036.36%	2,494.29%	-811.11%	792.59%	0.00%	3,650.00%	1,570.97%	2,862.50%	-2,120.00%	819.35%
Free Cash Flow to Firm to Interest Expense	-11.00	-24.80	-38.98	-34.97	-10.91	22.45	45.81	17.85	15.64	-13.73	14.03
Operating Cash Flow to Interest Expense	4.42	-6.59	30.10	-7.82	7.93	-25.56	35.15	18.04	32.71	-7.85	9.07
Operating Cash Flow Less CapEx to Interest Expense	3.91	-6.91	28.90	-8.79	6.93	-25.37	34.19	16.89	31.57	-8.22	7.96
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	2.62	2.66	2.56	2.59	2.48	2.50	2.40	2.49	2.51	2.61	2.62
Accounts Receivable Turnover	12.24	12.70	13.71	13.32	12.18	12.61	14.21	14.11	13.79	14.28	15.08
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	31.79	26.66	28.53	34.47	31.79	26.78	29.57	35.18	34.44	31.40	32.87
Days Sales Outstanding (DSO)	29.82	28.75	26.63	27.40	29.96	28.96	25.69	25.87	26.47	25.57	24.20
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	11.48	13.69	12.79	10.59	11.48	13.63	12.34	10.38	10.60	11.62	11.10
Cash Conversion Cycle (CCC)	18.34	15.05	13.83	16.81	18.48	15.33	13.34	15.49	15.87	13.94	13.10
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-1,721	-1,854	-2,401	-1,945	-2,525	-2,973	-3,879	-3,246	-3,141	-2,603	-2,907
Invested Capital Turnover	-19.72	-16.84	-12.48	-14.41	-12.66	-12.22	-9.80	-10.29	-10.46	-11.31	-10.99
Increase / (Decrease) in Invested Capital	804	1,119	1,478	1,301	616	-370	-972	-153	-96	446	-142
Enterprise Value (EV)	12,250	10,298	13,020	10,634	16,933	13,876	11,358	10,695	9,059	13,718	13,216
Market Capitalization	18,281	16,648	20,191	17,422	23,951	21,064	19,116	17,562	15,488	19,285	19,164
Book Value per Share	$77.66	$78.60	$81.40	$82.65	$76.67	$72.30	$66.54	$62.11	$56.79	$50.75	$52.34
Tangible Book Value per Share	$38.47	$44.72	$48.58	$50.00	$43.79	$47.44	$41.30	$38.99	$33.14	$26.95	$30.60
Total Capital	7,884	7,419	7,102	7,024	6,673	6,395	6,058	5,799	5,465	5,140	5,216
Total Debt	3,574	2,923	2,332	2,181	2,180	2,180	2,179	2,178	2,177	2,176	2,175
Total Long-Term Debt	3,574	2,923	2,332	2,181	2,180	2,180	2,179	2,178	2,177	2,176	2,175
Net Debt	-6,031	-6,350	-7,171	-6,788	-7,018	-7,188	-7,758	-6,867	-6,429	-5,567	-5,948
Capital Expenditures (CapEx)	22	11	35	27	27	-5.00	26	31	32	10	31
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-4,192	-4,110	-4,670	-4,206	-4,783	-4,733	-5,700	-4,892	-4,819	-4,276	-4,631
Debt-free Net Working Capital (DFNWC)	5,102	4,877	4,544	4,495	4,154	4,374	3,976	3,904	3,545	3,229	3,250
Net Working Capital (NWC)	5,102	4,877	4,544	4,495	4,154	4,374	3,976	3,904	3,545	3,229	3,250
Net Nonoperating Expense (NNE)	33	25	22	21	20	20	20	20	21	19	21
Net Nonoperating Obligations (NNO)	-6,031	-6,350	-7,171	-6,788	-7,018	-7,188	-7,758	-6,867	-6,429	-5,567	-5,948
Total Depreciation and Amortization (D&A)	48	48	47	46	45	43	42	42	44	47	45
Debt-free, Cash-free Net Working Capital to Revenue	-10.01%	-10.11%	-11.91%	-11.24%	-13.34%	-13.89%	-17.14%	-14.99%	-14.90%	-13.37%	-14.86%
Debt-free Net Working Capital to Revenue	12.19%	12.00%	11.59%	12.02%	11.59%	12.84%	11.96%	11.97%	10.96%	10.10%	10.43%
Net Working Capital to Revenue	12.19%	12.00%	11.59%	12.02%	11.59%	12.84%	11.96%	11.97%	10.96%	10.10%	10.43%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$5.47	$4.46	$5.67	$5.18	$5.21	$3.72	$4.24	$5.37	$5.58	$0.98	$4.00
Adjusted Weighted Average Basic Shares Outstanding	54.20M	57.40M	57.20M	58.60M	58.60M	57.70M	58.30M	58.30M	58.30M	57.80M	58.40M
Adjusted Diluted Earnings per Share	$5.45	$4.43	$5.65	$5.17	$5.17	$3.69	$4.21	$5.35	$5.52	$0.96	$3.95
Adjusted Weighted Average Diluted Shares Outstanding	54.20M	57.70M	57.20M	58.60M	58.60M	58.10M	58.30M	58.30M	58.30M	58.50M	58.40M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	54.20M	55.50M	57.20M	58.60M	58.60M	58.40M	58.30M	58.30M	58.30M	57.90M	58.40M
Normalized Net Operating Profit after Tax (NOPAT)	331	276	348	322	321	236	265	329	342	75	251
Normalized NOPAT Margin	2.97%	2.63%	3.36%	3.26%	3.24%	2.61%	3.10%	3.95%	4.20%	0.92%	3.17%
Pre Tax Income Margin	3.50%	3.30%	4.24%	4.11%	4.02%	3.19%	3.88%	5.00%	5.24%	0.95%	3.87%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	10.07	11.18	16.10	15.50	15.78	11.70	13.30	16.41	16.25	3.89	11.96
NOPAT to Interest Expense	7.69	8.11	11.99	11.49	11.90	8.75	9.81	12.19	12.22	2.79	8.96
EBIT Less CapEx to Interest Expense	9.56	10.85	14.90	14.54	14.78	11.89	12.33	15.26	15.11	3.52	10.86
NOPAT Less CapEx to Interest Expense	7.18	7.78	10.78	10.53	10.90	8.93	8.85	11.04	11.07	2.42	7.86
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	127.55%	84.82%	43.71%	0.00%	0.00%	0.00%	21.48%	0.00%	0.00%	50.51%	23.84%

Frequently Asked Questions About Molina Healthcare's Financials

When does Molina Healthcare's fiscal year end?

According to the most recent income statement we have on file, Molina Healthcare's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Molina Healthcare's net income changed over the last 9 years?

Molina Healthcare's net income appears to be on an upward trend, with a most recent value of $1.18 billion in 2024, rising from $143 million in 2015. The previous period was $1.09 billion in 2023. See Molina Healthcare's forecast for analyst expectations on what’s next for the company.

What is Molina Healthcare's operating income?

Molina Healthcare's total operating income in 2024 was $1.71 billion, based on the following breakdown:

Total Gross Profit: $6.22 billion
Total Operating Expenses: $4.52 billion

How has Molina Healthcare revenue changed over the last 9 years?

Over the last 9 years, Molina Healthcare's total revenue changed from $14.18 billion in 2015 to $40.65 billion in 2024, a change of 186.7%.

How much debt does Molina Healthcare have?

Molina Healthcare's total liabilities were at $11.13 billion at the end of 2024, a 4.3% increase from 2023, and a 121.8% increase since 2015.

How much cash does Molina Healthcare have?

In the past 9 years, Molina Healthcare's cash and equivalents has ranged from $2.33 billion in 2015 to $4.85 billion in 2023, and is currently $4.66 billion as of their latest financial filing in 2024.

How has Molina Healthcare's book value per share changed over the last 9 years?

Over the last 9 years, Molina Healthcare's book value per share changed from 27.76 in 2015 to 78.60 in 2024, a change of 183.1%.

Related Companies

This page (NYSE:MOH) was last updated on 5/21/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Molina Healthcare (MOH) Financials

Frequently Asked Questions About Molina Healthcare's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Molina Healthcare (MOH) Financials

Annual Income Statements for Molina Healthcare

Quarterly Income Statements for Molina Healthcare

Annual Cash Flow Statements for Molina Healthcare

Quarterly Cash Flow Statements for Molina Healthcare

Annual Balance Sheets for Molina Healthcare

Quarterly Balance Sheets for Molina Healthcare

Annual Metrics And Ratios for Molina Healthcare

Quarterly Metrics And Ratios for Molina Healthcare

Frequently Asked Questions About Molina Healthcare's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools